Federal health officials face a growing hurdle in their quest to persuade Americans of all ages and risk profiles to get updated COVID-19 boosters: strong proponents of vaccination.
From New England to the Bay Area, researchers voiced concerns to mainstream science and health publications in recent days that the one-size-fits-all model may be backfiring.
Read More
On Sunday, the chief executive officer of Pfizer said that Americans should be prepared to receive a second booster shot of the Coronavirus vaccine, which would mark the fourth overall shot that has been forced on the American public.
As reported by Politico, Albert Bourla made his remarks in an interview with CBS’ Margaret Brennan, where he said that his company was preparing to submit “a significant package of data about the need for a fourth dose” to the Food and Drug Administration (FDA).
Read More
The Michigan Department of Health and Human Services (MDHHS) ordered nursing homes statewide to provide on-site COVID-19 vaccines to residents within 30 days.
“With the Omicron variant rapidly spreading across our state and cases of COVID-19 continuing to remain high, we want to make sure our most vulnerable Michiganders are protected from the virus,” MDHHS Director Elizabeth Hertel said in a statement. “The COVID-19 vaccine is our best defense against the virus, and we want to ensure everyone has the opportunity to get up to date.”
Under the order, nursing homes must offer on-site doses of COVID-19 vaccines to residents who are not up to date as of Jan. 20, 2022. The order doesn’t force residents to get vaccinated.
Read More
The Food and Drug Administration (FDA) approved Moderna and Pfizer’s COVID-19 vaccines for booster shot use for adults in the U.S., the agency announced Friday,
The announcement was made just two months after the FDA first rejected the White House’s plan to administer booster shots to all adults the week of Sept. 20. FDA Acting Commissioner Janet Woodcock approved the booster without holding the usual public meeting to review the data, and the Centers for Disease Control and Prevention (CDC) will meet Friday afternoon to discuss the authorization, according to the FDA press release.
“Throughout the course of the COVID-19 pandemic, the FDA has worked to make timely public health decisions as the pandemic evolves. COVID-19 vaccines have proven to be the best and highly effective defense against COVID-19,” Woodcock said in the press release.
Read More